Sale of Puerto Rico Subsidiary

9 Months Ended

Sep. 30, 2022

Discontinued Operations and Disposal Groups [Abstract]

During the fourth quarter of 2020, the Company entered into a stock purchase agreement (the “SPA”) with one of its existing radiopharmacy customers to sell all the stock of its Puerto Rico radiopharmacy subsidiary. The assets were classified as held for sale and the Company determined that the fair value of the net assets being sold significantly exceeded the carrying value as of December 31, 2020. The transaction was consummated on January 29, 2021.

The purchase price for the stock sale was $18.0 million in cash, including a holdback amount of $1.8 million which the Company received during the first quarter of 2022; the purchase price also included a working capital adjustment. The SPA contains customary representations, warranties and covenants by each of the parties. Subject to certain limitations, the buyer will be indemnified for damages resulting from breaches or inaccuracies of the Company’s representations, warranties and covenants in the SPA.

The Company determined that this sale of certain net assets did not constitute a strategic shift that had a major effect on the Company’s operations or financial results. As a result, this transaction was not classified as discontinued operations in the Company’s accompanying condensed consolidated financial statements.

The following table summarizes the major classes of assets and liabilities sold as of January 29, 2021, the date of sale:



(in thousands)	January 29, 2021
Current Assets:
Cash and cash equivalents	$	540
Accounts receivable, net	1,959
Inventory	530
Other current assets	65
Total current assets	3,094
Non-Current Assets:
Property, plant & equipment, net	780
Intangibles, net	96
Other long-term assets	774
Total assets held for sale	$	4,744

Current Liabilities:
Accounts payable	$	185
Accrued expense and other liabilities	369
Total current liabilities	554
Non-Current Liabilities:
Asset retirement obligations	306
Other long-term liabilities	588
Total liabilities held for sale	$	1,448

The sale resulted in a pre-tax book gain of $15.3 million, which was recorded within operating income in the condensed consolidated statements of operations for the six months ended June 30, 2021.